AdvancedAntibodyDiscovery
Engineered for breakthroughs
Reprogramming Immunity, Precisely
Multi-specific platforms that deliver T cell co-stimulation,
tumor selectivity, and controlled payloads
Reprogramming
Immunity, Precisely
Multi-specific platforms that deliver
T cell co-stimulation,
tumor selectivity, and controlled payloads.
Engineered to reshape cancer therapy.
Learn more
Core Technologies
Innovative solutions driving the future of therapeutics
Bispecific ADC.
“Built to Wait.
Wired to Strike.”
Conditionally active payloads that engage only when the environment is right.
T cell engager.
“Engineer the Synapse.
Elevate the Response.”
Trispecific TCEs designed for precision engagement and deeper activation.
Pioneering expertise in
antibody and
immunotherapy
Cyron Therapeutics is committed to breakthrough
solutions for patients, leveraging advanced antibody
engineering, ADCs, and T-cell engager platforms.
